We therefore advocate the British Society of Haematology (BSH) Expert Haematology Panel recommendations to test for anti‐PF4 antibodies in patients with thrombocytopenia, thrombosis and a D‐dimer of >4000 ng/mL regardless of vaccine exposure.11 This evidence concerns the gene PF4 and deep vein thrombosis.